PURPOSE
Massive pulmonary embolism (PE) causes hemodynamic compromise and is associated with a high rate of mortality. We sought to create a model of massive PE and to determine whether occlusion of the right main bronchus could mitigate the physiological effects of massive PE in this model.
MATERIALS AND METHODS
We used 27 female sheep to generate a model of massive PE by either autologous blood clot injection (n=18) or detachable balloon release (n=9) into the right main pulmonary artery. Four sheep were excluded after blood clot injection, as they did not exhibit adequate declines in blood oxygen saturation (SaO 2 ). Nine of the sheep that received autologous blood clot and nine that received detachable balloons went on to treatment with right main bronchus occlusion. The control group (n=5) received the autologous blood clot, but no occlusion of the right main bronchus. All sheep underwent continuous monitoring of pulmonary arterial mean pressure (PAMP), SaO 2 , arterial partial pressure of oxygen (PaO 2 ), and arterial partial pressure of carbon dioxide.
RESULTS
Twenty-three sheep (85%) subjected to PE demonstrated immediate tachycardia, tachypnea, and decline in SaO 2 of at least 25% within 30 min. After right main bronchus occlusion, 18 sheep (100%) survived for the length of the experiment and exhibited persistently higher SaO 2 and PaO 2 levels, as well as decreased PAMP compared with the controls. In the control group, two out of five sheep died within 30 min, and the three surviving subjects demonstrated significantly decreased SaO 2 and PaO 2 levels.
CONCLUSION
Occlusion of the right main bronchus in an ovine model of massive PE effectively extends life and provides favorable physiological parameters to allow emergent interventions.
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Creation of the massive PE model
Next, we produced a model of massive PE by one of two methods: autologous clot or balloon occlusion. The autologous clot was formed ex vivo (0.6 mL/kg) and was injected into the right main pulmonary arteries of 18 sheep via a 12 F guiding catheter (14, 15) (Fig. 1) . We released a selfmade detachable 15-to 20-mm latex balloon into the right main pulmonary artery of the other nine sheep (16) (Fig. 2) . After injection of the autologous blood clot or release of the detachable balloon, immediate pulmonary angiography was performed to demonstrate occlusion of the right main pulmonary artery. Once PE was established, it was deemed to be massive only if the blood oxygen saturation (SaO 2 ) levels dropped by at least 25% from resting levels. We continuously monitored CVP and PAMP until levels stabilized (approximately 30 min) to ensure that massive PE had been effectively produced.
Balloon occlusion of the right main bronchus
We evaluated the physiological consequences of obstructing airflow to the right lung in subjects exhibiting a precipitous drop in SaO 2 (25% or greater). We inflated a 12×40-mm balloon (Cordis Corporation, Johnson and Johnson Medical Ltd., Bridgewater, New Jersey, USA) in the right main bronchus and recorded PAMP, SaO 2 , and PaO 2 at 0, 3, 6, 10, 15, 20, 30, 45, and 60 min. Control subjects (n=5) were sheep that had received an autologous blood clot in the right main pulmonary artery but did not undergo balloon occlusion of the right main bronchus.
Statistical analysis
All quantitative data are presented as the means±standard deviations. The results were compared and analyzed with Fisher's exact test for survival rate, t-tests for group comparison, and the F-test for the analysis of effectiveness, as related to duration in the experimental groups. Statistical significance was defined as P < 0.05. The results were analyzed using a commercially available software (Statistical Package for Social Sciences, version 11, SPSS Inc., Chicago, Illinois, USA).
(0.2 mL/kg), ketamine (7.5 mg/kg), and diazepam (0.25 mg/kg) followed by maintenance with a continuous intravenous drip of ketamine and diazepam. Previously described general animal care guidelines were followed (12) . One or two sheep were studied per day.
The sheep were placed in the supine position, and a single lumen tracheal tube was inserted. Short vascular sheaths (Cook Medical, Bloomington, Indiana, USA) were placed, as follows: 1) on the right, a single 12 F sheath was inserted into the common femoral vein; 2) on the left, a 4 F sheath was inserted into the common femoral artery; and two 4 F sheaths were inserted into the common femoral vein. From the right-sided sheath, we withdrew 50 mL of blood and incubated the blood in a flask at 40 °C for two hours to promote clotting (13) . During the incubation period, a fluoroscopically guided 4 F pigtail catheter (Cook Medical) was advanced into the abdominal aorta for continuous monitoring of the mean arterial pressure. Two additional 4 F pigtail catheters were advanced to continuously monitor central venous pressure (CVP) via the superior vena cava and PAMP via the main pulmonary artery. 
Results

Successful creation of the massive PE model
All 27 sheep immediately developed tachycardia and tachypnea after right main pulmonary arterial delivery of the detachable balloon (n=9) or autologous blood clot (n=18). 
Right main bronchus occlusion ameliorates the physiological effects of massive PE
After 30 min of monitoring to assure adequate creation of massive PE, we deployed a right main bronchus balloon in animals of both treatment groups. The most salient finding was a significant difference in survival between the treated and control animals. In the control group, two of the five sheep died within 30 min. The remaining three sheep in the control group survived the entire length of the experiment despite low oxygen saturation levels. By comparison, all of the animals that underwent right main bronchus balloon occlusion survived for the duration of the experiment (P = 0.0395).
In addition to reduced mortality, treatment groups also demonstrated decreased hypoxemia. SaO 2 levels began to increase in both groups by 3 min after balloon inflation. For the autologous clot group, statistical significance was observed at t=30 min, reaching levels of 73.11±13.17% (P = 0.0234) compared with SaO 2 levels of 58.22±12.02% at t=0. SaO 2 levels continued to rise with time and remained significantly greater compared with the baseline, reaching 79.56±8.26% at 45 min (P = 0.0005) and 80.11±15.46% at one hour (P = 0.0040). In the balloon occlusion group, baseline t=0 SaO 2 levels were 67.44±6.42% and reached statistical significance at t=20 min (75.44±9.3%, P = 0.0496). SaO 2 levels continued to increase over time, remaining significantly elevated at t=30 min (78.75±7.92%, P = 0.0043), at t=45 min (82.63±6.32%, P = 0.0001) and at t=1 hour (84.89±5.90%, P < 0.0001).
In comparison, SaO 2 levels in the five control sheep that did not undergo right main bronchus balloon occlusion remained persistently low. After 30 min, autologous clot injection (equivalent to t=0 in the treatment subjects), the surviving three sheep of the control group displayed SaO 2 levels of 53.50±14.85%. After 30 min, SaO 2 levels were 53.00±18.52% (P > 0.5).
In addition to decreasing hypoxemia, balloon occlusion of the right main bronchus was also associated with a trend toward increasing PaO 2 . At baseline, PaO 2 levels were 56.64±15.16 mmHg for controls, 49.70±14.73 mmHg for the autologous clot group and 58.85±15.35 mmHg for the balloon occlusion group. After 30 min, the three surviving control sheep had significantly reduced PaO 2 compared with the baseline (32.30±8.86 mmHg, P = 0.0473), whereas the treated sheep experienced a non-significant trend toward an increase in PaO 2 (autologous clot group, 60.74±12.75 mmHg; balloon occlusion group, 70.66±29.28 mmHg; P > 0.5).
Following balloon occlusion of the right main bronchus in the treated group, PAMP levels ranged from approximately 33 to 37 mmHg and demonstrated no statistical significance throughout the one-hour experimental period. However, in the five sheep that made up the control group, PAMP levels initially rose from normal levels of 21.78±5.54 mmHg to 41.17±15.75 mmHg. Following this initial increase, PAMP levels decreased significantly to levels of 18.50±4.95 mmHg, while two sheep died from massive PE. Fig.  3 depicts the changes in the values described above.
Discussion
Massive PE is a worldwide public health problem with a high mortality rate. Death often occurs within the first hour of presentation from a predictable cascade of physiologic derangements due to ventilation-perfusion mismatch, including redistribution of pulmonary blood flow, elevated capillary permeability, decreased levels of pulmonary surfactant, and increased atelectasis. PE leads to pulmonary arterial hypertension with eventual right heart failure (17, 18) .
The most significant finding of our study, which utilized an ovine massive PE model, was that occlusion of the right main bronchus attenuated many of these often fatal hemodynamic changes. After inflation of an occlusive balloon in the right main bronchus, all 18 animals undergoing massive PE survived until the end of the experiment compared with the control sheep, of which three out of five died (19) . Right main bronchus occlusion decreased PE-induced hypoxemia, inducing a significant increase in SaO 2 and a trend toward increased PaO 2 .
We developed two ovine models of massive PE, both of which were validated by measuring hemodynamic parameters. Both models demonstrated physiological derangements characteristic of PE, including decreased SaO 2 and PaO 2 and increased PAMP. The experiments using autologous blood clot involved injection via a 12 F guiding catheter, providing a maximal diameter of only 4 mm, thereby limiting the size of the blood clot that could be delivered. Therefore, pulmonary arterial occlusion may have been localized more distally in smaller pulmonary vessels. To assure that a model of massive PE had been achieved, only sheep with a 25% drop in oxygen saturation and with a visibly extensive clot burden in the main pulmonary artery (as determined by angiography) were included in the study. We included the additional PE model with balloon occlusion of the right pulmonary artery to provide data related to more central arterial occlusion. The results obtained via both modalities were similar, suggesting that both models similarly depict PE. Arguably, a large central clot burden from peripheral pulmonary arterial emboli may reflect the PE observed clinically in human patients more accurately.
Hypothetically, by reducing the ventilation-perfusion mismatch, bronchial occlusion attenuates many of the physiological effects of PE. Maintaining improved blood oxygen saturation theoretically allows more time to perform potentially life-saving thrombolysis and/or thrombectomy. In conclusion, balloon occlusion of the right main bronchus in an ovine massive pulmonary embolus model produces a setting in which SaO 2 and PaO 2 are increased and PAMP is decreased. This intervention successfully widens the time-to-treatment window to allow more time for surgical or endovascular treatments.
